Home

RECOMBINANT PROTEINS
PREVIOUSLY OUT OF REACH

SCALABLE VIRAL VECTOR PRODUCTION

C1-INHIBITOR AND ALKALINE
PHOSPHATASE: GLYCO-OPTIMIZED
FOR THERAPEUTIC NEEDS

STABLE AAV PRODUCER CELL LINES

Meet us at

CELL & GENE THERAPY WORLD

01/22/2018 – 01/25/2018 – MIAMI, USA

Listen to the talk of Dr. Nicole Faust
on Stable AAV Vector Production

January 24TH AT 11.20AM-12:35PM

Career

Open position

Technischer Assistent Virale Vektoren (m/w)

© Copyright – CEVEC 2017